DANIEL VALCICAK: Open Payments
NPI 1063172831 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 22 payments from 15 companies in 2025. Trend: 2023 $480 · 2024 $1,618 · 2025 $598
Food & beverage: $580Education: $18
| Company | Payments | Amount |
|---|---|---|
| Philips North America LLC | 1 | $102 |
| Novartis Pharmaceuticals Corporation | 4 | $96 |
| Boston Scientific Corporation | 2 | $79 |
| Kestra Medical Technology Services, Inc. | 2 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $43 |
| Esperion Therapeutics, Inc. | 1 | $33 |
| Amgen Inc. | 2 | $29 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Teleflex LLC | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: ECC Solutions, LEQVIO, Assure WCD, WATCHMAN, NEXLETOL, VERQUVO, CAMZYOS, CHOCOLATE.
Industry payments across VA — which companies pay providers there.
